Skip to main content
NCBI home page
Anesthesia Progress logoLink to Anesthesia Progress
. 2000 Spring;47(2):29–34.

Oral transmucosal fentanyl pretreatment for outpatient general anesthesia.

P A Moore 1, M A Cuddy 1, J A Magera 1, A C Caputo 1, A H Chen 1, L A Wilkinson 1
PMCID: PMC2149014  PMID: 11881693

Abstract

The oral transmucosal formulation of fentanyl citrate (OTFC) has been reported to be an effective sedative, providing convenient and atraumatic sedation for children prior to general anesthesia or painful diagnostic procedures. Thirty-three young children (24-60 months of age) scheduled for outpatient general anesthesia for treatment of dental caries were enrolled in this randomized placebo-controlled clinical trial. To determine the effectiveness of the OTFC premedication, patient behavior was evaluated using three distinct outcome ratings. A sedation score rated behavior in the waiting room prior to OTFC as well as 10 minutes and 20 minutes after OTFC. A separation score rated the child's response to being separated from his/her parent or guardian for transport to the dental operatory. Finally, a cooperation score rated the child's acceptance of the mask induction. The OTFC formulation was well tolerated by most of the children in this study. Compared with the placebo oralet, the active OTFC improved behavior for separation from the parent (P < .05) and cooperation with the mask induction (P < .05). The duration of surgery and the time of recovery did not differ between placebo and active premedication. Side effects including respiratory and cardiovascular complications were reported more frequently in the active fentanyl group. Continuous monitoring of respiratory function is essential when using this unique and effective formulation of fentanyl for pediatric preanesthetic sedation.

Full text

PDF
29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coté C. J. Sedation for the pediatric patient. A review. Pediatr Clin North Am. 1994 Feb;41(1):31–58. doi: 10.1016/s0031-3955(16)38690-4. [DOI] [PubMed] [Google Scholar]
  2. Dsida R. M., Wheeler M., Birmingham P. K., Henthorn T. K., Avram M. J., Enders-Klein C., Maddalozzo J., Coté C. J. Premedication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate. Anesth Analg. 1998 Jan;86(1):66–70. doi: 10.1097/00000539-199801000-00013. [DOI] [PubMed] [Google Scholar]
  3. Farrar J. T., Cleary J., Rauck R., Busch M., Nordbrock E. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst. 1998 Apr 15;90(8):611–616. doi: 10.1093/jnci/90.8.611. [DOI] [PubMed] [Google Scholar]
  4. Ginsberg B., Dear R. B., Margolis J. O., Dear G. D., Ross A. K. Oral transmucosal fentanyl citrate as an anaesthetic premedication when dosed to an opioid effect vs total opioid consumption. Paediatr Anaesth. 1998;8(5):413–418. doi: 10.1046/j.1460-9592.1998.00276.x. [DOI] [PubMed] [Google Scholar]
  5. Haas D. A. Adverse drug interactions in dental practice: interactions associated with analgesics, Part III in a series. J Am Dent Assoc. 1999 Mar;130(3):397–407. doi: 10.14219/jada.archive.1999.0210. [DOI] [PubMed] [Google Scholar]
  6. Lambert L. A., Nazif M. M., Moore P. A., Zullo T. G. Nonlinear dose-response characteristics of alphaprodine sedation in preschool children. Pediatr Dent. 1988 Mar;10(1):30–33. [PubMed] [Google Scholar]
  7. Lichtor J. L., Sevarino F. B., Joshi G. P., Busch M. A., Nordbrock E., Ginsberg B. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain. Anesth Analg. 1999 Sep;89(3):732–738. doi: 10.1097/00000539-199909000-00038. [DOI] [PubMed] [Google Scholar]
  8. McKee K. C., Nazif M. M., Jackson D. L., Barnhart D. C., Close J., Moore P. A. Dose-responsive characteristics of meperidine sedation in preschool children. Pediatr Dent. 1990 Jul-Aug;12(4):222–227. [PubMed] [Google Scholar]
  9. Moore P. A. Adverse drug interactions in dental practice: interactions associated with local anesthetics, sedatives and anxiolytics. Part IV of a series. J Am Dent Assoc. 1999 Apr;130(4):541–554. doi: 10.14219/jada.archive.1999.0250. [DOI] [PubMed] [Google Scholar]
  10. Moore P. A., Finder R. L., Jackson D. L. Multidrug intravenous sedation: determinants of the sedative dose of midazolam. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jul;84(1):5–10. doi: 10.1016/s1079-2104(97)90285-7. [DOI] [PubMed] [Google Scholar]
  11. Moore P. A., Goodson J. M. Risk appraisal of narcotic sedation for children. Anesth Prog. 1985 Jul-Aug;32(4):129–139. [PMC free article] [PubMed] [Google Scholar]
  12. Moore P. A. Pain control in dentistry: pediatric pharmacosedation. Compendium. 1987 Jan;8(1):28, 30-6, 38-9. [PubMed] [Google Scholar]
  13. Portenoy R. K., Payne R., Coluzzi P., Raschko J. W., Lyss A., Busch M. A., Frigerio V., Ingham J., Loseth D. B., Nordbrock E. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain. 1999 Feb;79(2-3):303–312. doi: 10.1016/s0304-3959(98)00179-1. [DOI] [PubMed] [Google Scholar]
  14. Schechter N. L., Weisman S. J., Rosenblum M., Bernstein B., Conard P. L. The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics. 1995 Mar;95(3):335–339. [PubMed] [Google Scholar]
  15. Schutzman S. A., Liebelt E., Wisk M., Burg J. Comparison of oral transmucosal fentanyl citrate and intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation of children undergoing laceration repair. Ann Emerg Med. 1996 Oct;28(4):385–390. doi: 10.1016/s0196-0644(96)70001-x. [DOI] [PubMed] [Google Scholar]
  16. Sharar S. R., Bratton S. L., Carrougher G. J., Edwards W. T., Summer G., Levy F. H., Cortiella J. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil. 1998 Nov-Dec;19(6):516–521. doi: 10.1097/00004630-199811000-00010. [DOI] [PubMed] [Google Scholar]
  17. Streisand J. B., Busch M. A., Egan T. D., Smith B. G., Gay M., Pace N. L. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate. Anesthesiology. 1998 Feb;88(2):305–309. doi: 10.1097/00000542-199802000-00006. [DOI] [PubMed] [Google Scholar]
  18. Streisand J. B., Varvel J. R., Stanski D. R., Le Maire L., Ashburn M. A., Hague B. I., Tarver S. D., Stanley T. H. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology. 1991 Aug;75(2):223–229. doi: 10.1097/00000542-199108000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Anesthesia Progress are provided here courtesy of American Dental Society of Anesthesiology

RESOURCES